SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 206.01-0.4%Nov 19 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: schadenfreude who wrote (20557)5/12/1998 3:40:00 AM
From: Torben Noerup Nielsen  Read Replies (2) of 32384
 
>Perhaps SRGN is worth the dilution, but I suspect that this is one
>more piece of LGND's plan to build a large, diversified company
>whether it is in the interests of shareholders or not. In other
>industries they call it empire building.

But don't you think that Robinson's pay is related to how well LGND does? I would assume that he has quite a few options and their value will rise in direct proportion to the value of LGND.... Wouldn't this be the case for all of the key decision makers in the company?

What is interesting to me is that most everyone here seems to dislike the deal. But Robinson and crew must obviously like it. They did have an alternative; the LLY agreement did not obligate them to take the drug at all.....

So what am I missing? Quite possibly I am just being stupid and not seing the obvious....

Cheers, Torben
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext